Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer [1]

Lung Cancer

Volumn 51, Issue 3, 2006, Pages 387-388

  Nandan, Raghu ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BEXAROTENE; CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; FENOFIBRATE; RETINOIC ACID; RETINOID;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; HEADACHE; HUMAN; HYPERLIPIDEMIA; LETTER; LEUKOCYTOSIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RASH; RETINOIC ACID SYNDROME; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL AVAILABILITY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME; TRETINOIN;

EID: 33144462044     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.11.003     Document Type: Letter

References (6)

1. J. Treat, D. Friedland, and W. Luginbuhl Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer Cancer Invest 14 1996 415 420
2. R. Thiruvengadam, J.O. Atiba, and S.H. Azawi A phase II trial of a differentiating agent (tRA) with cisplatin-VP-16 chemotherapy in advanced non-small cell lung cancer Invest New Drugs 14 1996 395 401
3. J.O. Atiba, A.M. Manzardo, and R. Thiruvengadam Effect of a drug holiday on all-trans retinoic acid pharmacokinetics Am J Ther 4 1997 134 140
4. F.R. Khuri, J.R. Rigas, and R.A. Figlin Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer J Clin Oncol 19 2001 2626 2637
5. G.R. Blumenschein, F. Khuri, and U.W. Gatzemeier A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) J Clin Oncol 23 2005 16s (suppl., abstract LBA7001)
6. J. Jassem, Zatloukal, and R. Ramiau A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) J Clin Oncol 23 2005 16s (suppl., abstract LBA7024)